Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved.

摘要

In patients with preserved EF, candesartan reduces the rate of admissions for worsening heart failure, to a greater extent than apparent from analysing only first hospitalizations. Recurrent events should be routinely incorporated into the analysis of future clinical trials in heart failure.